dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Andrade, Fernanda |
dc.contributor.author | Roca-Melendres, Maria Mercè |
dc.contributor.author | Durán-Lara, Esteban F. |
dc.contributor.author | Schwartz Navarro, Simon |
dc.contributor.author | Rafael, Diana |
dc.date.accessioned | 2022-03-30T09:27:19Z |
dc.date.available | 2022-03-30T09:27:19Z |
dc.date.issued | 2021-03 |
dc.identifier.citation | Andrade F, Roca-Melendres MM, Durán-Lara EF, Rafael D, Schwartz S. Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field. Cancers. 2021 Mar;13(5):1164. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7276 |
dc.description | Tractament contra el càncer; Hidrogels; Fotosensible |
dc.description.sponsorship | This work was supported by ANID FONDECYT REGULAR (Chile) through project Nº 1210476 from Esteban F. Durán-Lara. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(5) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Tractament |
dc.subject | Col·loides - Ús terapèutic |
dc.subject | Medicaments - Modes d'administració |
dc.subject.mesh | Hydrogels |
dc.subject.mesh | /chemistry |
dc.subject.mesh | Drug Delivery Systems |
dc.subject.mesh | Neoplasms |
dc.title | Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13051164 |
dc.subject.decs | hidrogeles |
dc.subject.decs | /química |
dc.subject.decs | sistemas de liberación de medicamentos |
dc.subject.decs | neoplasias |
dc.relation.publishversion | https://doi.org/10.3390/cancers13051164 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Andrade F] Grup d'Orientació i Distribució de Medicaments, Recerca en Biologia Molecular i Bioquímica, Centre de Nanomedicina (CIBBIM-Nanomedicina), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Roca-Melendres MM] Grup d'Orientació i Distribució de Medicaments, Recerca en Biologia Molecular i Bioquímica, Centre de Nanomedicina (CIBBIM-Nanomedicina), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Durán-Lara EF] Bio and NanoMaterials Lab, Drug Delivery and Controlled Release, Universidad de Talca, Talca 3460000, Maule, Chile. Departamento de Microbiología, Facultad de Ciencias de la Salud, Universidad de Talca, Talca 3460000, Maule, Chile. [Rafael D, Schwartz S Jr] Grup d'Orientació i Distribució de Medicaments, Recerca en Biologia Molecular i Bioquímica, Centre de Nanomedicina (CIBBIM-Nanomedicina), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Networking Research Centre for Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain |
dc.identifier.pmid | 33803133 |
dc.identifier.wos | 000627971800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |